Lung Cancer

Radiotherapy does not alter immunotherapy outcomes in metastatic NSCLC

Using radiotherapy to convert immunologically “cold” tumours into “hot” ones does not enhance the efficacy of checkpoint inhibitors in metastatic non-small cell lung cancer, Australian research shows. No difference in efficacy or toxicity was seen in NSCLC patients who had radiotherapy around the time of  starting treatment with anti-PD- 1 immunotherapy compared to patients who ...

Already a member?

Login to keep reading.

© 2021 the limbic